Heterotopic heart transplantation in 1988--recent selective indications and outcome

H Reichenspurner1, A Hildebrandt, D Boehm

  • 1Department of Cardiothoracic Surgery, University of Cape Town Medical School, Groote Schuur Hospital, South Africa.

The Journal of Heart Transplantation
|September 1, 1989
PubMed

Insights

Heterotopic heart transplantation remains indicated for specific cases, such as elevated pulmonary vascular resistance or significant size mismatch, showing an 83% 1-year survival rate. This procedure improves cardiac output and reduces pulmonary vascular resistance in select heart transplant recipients.

Area of Science:

  • Cardiology
  • Transplantation Surgery
  • Immunology

Background:

  • Orthotopic heart transplantation (OHT) boasts a high 1-year survival rate (nearly 90%).
  • This raises questions about the continued role of heterotopic heart transplantation (HHT).
  • This study reviews HHT outcomes at an institution with evolving immunosuppression protocols.

Purpose of the Study:

  • To evaluate the indications and outcomes of heterotopic heart transplantation.
  • To assess the efficacy of quadruple-drug immunosuppression therapy in heart transplant patients.
  • To determine the impact of HHT on cardiac function and pulmonary hemodynamics.

Main Methods:

  • Review of 132 heart transplantations performed since 1967.
  • Analysis of 11 heterotopic heart transplantations performed between 1974-1983 and since 1985 with quadruple-drug immunosuppression.
  • Quadruple-drug therapy: low-dose cyclosporine, azathioprine, methylprednisolone, and rabbit antithymocyte globulin.
  • Right-sided heart catheterization for hemodynamic assessment post-transplantation.

Main Results:

  • 11 HHT patients had indications of elevated pulmonary vascular resistance (PVR) or donor-recipient weight mismatch.
  • The 1-year survival rate for HHT patients was 83%; 7 of 11 patients are currently alive.
  • Significant improvements in cardiac output (4.0 to 5.8 L/min) and decreases in PVR (4.9 to 2.4 Wood units) were observed post-HHT.

Conclusions:

  • Heterotopic heart transplantation remains a viable option for specific complex cases not suitable for OHT.
  • The implemented quadruple-drug immunosuppression regimen is effective in managing heart transplant recipients.
  • HHT effectively improves cardiac function and reduces pulmonary hypertension in selected patients.

Related Concept Videos